Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

UNC Libraries(2020)10.17615/f90j-yp81Source: DataRank Database

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: greenTopics (48)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Liam Murray ORCID,Marilie D. Gammon ORCID,Nirmala Pandeya ORCID,Thomas L. Vaughan ORCID,Carol Giffen ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4301491384

Health Research Board

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1U01CA057949-01

EPIDEMIOLOGIC STUDY OF ADENOCARCINOMAS OF THE ESOPHAGUS

National Institutes of Health

Grant: 5U01CA057983-02

ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIA

National Health and Medical Research Council (NHMRC)

Grant: 199600

Towards cancer control: Population and molecular strategies

National Institutes of Health

Grant: 5U01CA057923-03

EPIDEMIOLOGIC STUDY OF ESOPHAGEAL/GASTRIC ADENOCARCINOMA

FWCI

0.00

Citation Percentile

0.4%

greenLicense: Elsevier TDM

repositoryhttps://doi.org/10.17615/f90j-yp81

https://doi.org/10.1053/j.gastro.2011.11.019

https://cdr.lib.unc.edu/downloads/r494vr88h

https://dx.doi.org/10.17615/f90j-yp81

https://pubmed.ncbi.nlm.nih.gov/22108196

Fields of Study

Esophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studies03 medical and health sciences0302 clinical medicine

Keywords

Esophagogastric junctionNonsteroidalDrugEsophagusPooled analysisMedicineInternal medicineGastroenterologyBarrett's esophagusAdenocarcinomaPharmacologyCancerMeta-analysisAdultMaleCanadaAdolescentEsophageal Neoplasms610Stomach Cancer310Risk AssessmentCohort StudiesBarretts esophagusOdds RatioAnticarcinogenic AgentsHumans2715 GastroenterologyBeaconEsophageal NeoplasmAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalAustralia/dk/atira/pure/subjectarea/asjc/2700/2715Selective Cyclooxygenase 2 InhibitionMiddle AgedLogistic Modelsname=GastroenterologyCase-Control StudiesAnti Inflammatory AgentFemaleGastric cancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being